Inventor
IWASA SUSUMU
JP27 patents
⚠️ This page may combine multiple inventors who share the name “IWASA SUSUMU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TAKEDA CHEMICAL INDUSTRIES LTD
26 patentsUS6197350B1Mar 6, 2001
Method of producing a sustained-release preparation
TAKEDA CHEMICAL INDUSTRIES LTD447 citations98
US6117455ASep 12, 2000
Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
TAKEDA CHEMICAL INDUSTRIES LTD200 citations98
US6190702B1Feb 20, 2001
Sustained-released material prepared by dispersing a lyophilized polypeptide in an oil phase
TAKEDA CHEMICAL INDUSTRIES LTD98 citations97
US6190695B1Feb 20, 2001
Pharmaceutical composition containing osteogenesis-promoting substance
TAKEDA CHEMICAL INDUSTRIES LTD52 citations96
US5948773ASep 7, 1999
Formulation comprising antibacterial substance and antiulcer substance
TAKEDA CHEMICAL INDUSTRIES LTD57 citations96
US5876756AMar 2, 1999
Microcapsule containing amorphous water-soluble 2-piperazinone-1-acetic acid compound
TAKEDA CHEMICAL INDUSTRIES LTD78 citations95
US4517290AMay 14, 1985
Method for enzyme immunoassay and peptide-enzyme conjugate and antibody therefor
TAKEDA CHEMICAL INDUSTRIES LTD33 citations93
US4496658AJan 29, 1985
Method for enzyme immunoassay and production of antibody
TAKEDA CHEMICAL INDUSTRIES LTD34 citations93
US6191107B1Feb 20, 2001
Complex of human growth hormone and zinc
TAKEDA CHEMICAL INDUSTRIES LTD20 citations92
US6113941ASep 5, 2000
Substained release microcapsule of physiologically active compound which is slightly water soluble at pH 6 to 8
TAKEDA CHEMICAL INDUSTRIES LTD36 citations92
US5496549AMar 5, 1996
Bispecific monoclonal antibodies, thrombolytic agent and method of cell lysis
TAKEDA CHEMICAL INDUSTRIES LTD112 citations92
US5217713AJun 8, 1993
Cytotoxic bispecific monoclonal antibody, its production and use
TAKEDA CHEMICAL INDUSTRIES LTD27 citations91
US5141736AAug 25, 1992
Bispecific monoclonal antibody, its production and use
TAKEDA CHEMICAL INDUSTRIES LTD48 citations91
US5910492AJun 8, 1999
Osteogenic promoting pharmaceutical composition
TAKEDA CHEMICAL INDUSTRIES LTD23 citations89
US4059491ANov 22, 1977
Diluents for rubella virus hemagglutination-inhibition test
TAKEDA CHEMICAL INDUSTRIES LTD15 citations74
US6482864B1Nov 19, 2002
Sustained-release preparation of physiologically active polypeptide and production thereof
TAKEDA CHEMICAL INDUSTRIES LTD13 citations73
US6399103B1Jun 4, 2002
Method of producing a sustained-release preparation
TAKEDA CHEMICAL INDUSTRIES LTD11 citations73
US6319904B1Nov 20, 2001
Formulation comprising antibacterial substance and antiulcer substance
TAKEDA CHEMICAL INDUSTRIES LTD9 citations73
US5814324ASep 29, 1998
Injectable composition and a method of producing the same
TAKEDA CHEMICAL INDUSTRIES LTD8 citations73
US5665570ASep 9, 1997
Antibody-encoding recombinant DNA and its use
TAKEDA CHEMICAL INDUSTRIES LTD9 citations72
US4140754AFeb 20, 1979
Hemagglutination-inhibition test for togaviruses
TAKEDA CHEMICAL INDUSTRIES LTD6 citations63
US6429296B2Aug 6, 2002
Complex of human growth hormone and zinc and use
TAKEDA CHEMICAL INDUSTRIES LTD4 citations62
US5506135AApr 9, 1996
Hybrid monoclonal antibodies, their production and use
TAKEDA CHEMICAL INDUSTRIES LTD2 citations62
US5175268ADec 29, 1992
DNA encoding recombinant human lymphotoxin
TAKEDA CHEMICAL INDUSTRIES LTD4 citations62
US5142026AAug 25, 1992
Recombinant human lymphotoxins that possess N-terminal extended linker peptides for antibody-binding sites
TAKEDA CHEMICAL INDUSTRIES LTD1 citations50
US4312943AJan 26, 1982
Method for enzyme immunoassay of pancreatic glucagon
TAKEDA CHEMICAL INDUSTRIES LTD1 citations50